Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate

NCT00950989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Brodalumab
DRUG: Placebo
DRUG: Methotrexate
DIETARY_SUPPLEMENT: folic acid

Sponsor

Amgen